Application of digital twins for personalized oncology

Uzma Saddia Asghar^{1

2

3}, Caroline Chung^{4

5

6}

Affiliations

¹ Concr, London, UK. uzma@concr.co.
² Breast Unit, Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK. uzma@concr.co.
³ Medical Oncology, Breast Unit, Guys and St Thomas's NHS Foundation Trust, London, UK. uzma@concr.co.
⁴ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Uzma Saddia Asghar et al. Nat Rev Cancer. 2025 Nov.

. 2025 Nov;25(11):823-825.

doi: 10.1038/s41568-025-00850-7.

Uzma Saddia Asghar^{1

2

3}, Caroline Chung^{4

5

6}

¹ Concr, London, UK. uzma@concr.co.
² Breast Unit, Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK. uzma@concr.co.
³ Medical Oncology, Breast Unit, Guys and St Thomas's NHS Foundation Trust, London, UK. uzma@concr.co.
⁴ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Conflict of interest statement

Competing interests: U.S.A. is the chief scientific officer for Concr and receives a salary. C.C. declares no competing interests.

1. National Academies of Sciences, Engineering, and Medicine. Foundational research gaps and future directions for digital twins. https://doi.org/10.17226/26894 (National Academies Press, 2024).
1. Leslie, M. “Digital twins” may improve treatment prediction. Cancer Discov. https://doi.org/10.1158/2159-8290.CD-NW2024-0091 (2023). - DOI
1. Attaran, M. & Celik, B. G. Digital twin: benefits, use cases, challenges, and opportunities. Decision Analytics J. 6, 100165 (2023). - DOI
1. Sparano, J. A. et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N. Engl. J. Med. 379, 111–121 (2018). - DOI - PubMed - PMC
1. Tutt, A. N. J. et al. Adjuvant olaparib for patients with BRCA1 - or BRCA2-mutated breast cancer. N. Engl. J. Med. 384, 2394–2405 (2021). - DOI - PubMed - PMC